Study of V617F JAK2-positive and JAK2-negative patients within 18 families with myeloproliferative disorders (MPD): Disease characteristics and evolution, EPOR and MPL analysis.

被引：0
|
作者：
Bellanne-Chantelot, Christine
Labopin, Myriam
Bellanger, Florence
Chaumarel, Isabelle
Isnard, Franpoise
Casadevall, Nicole
Vainchenker, William
Thomas, Gilles
Najman, Albert
机构：
[1] Univ Paris 06, Dept Genet, APHP St Antoine, Paris, France
[2] INSERM, U790, IGR, Villejuif, France
[3] Dept Canc Epidemiol & Genet, Gaithersburg, MD USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
672
引用
收藏
页码：202A / 202A
页数：1
相关论文
共 50 条
  • [21] Myeloid blasts in transformed JAK2-V617F positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.
    Theocharides, Alexandre
    Boissinot, Marjorie
    Garand, Richard
    Girodon, Francois
    Teo, Soon-Siong
    Lippert, Eric
    Tichelli, Andre
    Hermouet, Sylvie
    Skoda, Radek C.
    BLOOD, 2006, 108 (11) : 115A - 115A
  • [22] Prevalence of JAK2 V617F mutation in Indian patients with chronic myeloproliferative disorders
    Sazawal, Sudha
    Bajaj, Jyoti
    Chikkara, Sunita
    Jain, Sonal
    Bhargava, Rahul
    Mahapatra, Manoranjan
    Saxena, Renu
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2010, 132 (04) : 423 - 427
  • [23] Evaluation of V617F mutation of JAK2 in negative chromosome Philadelphia chronic myeloproliferative disorders
    Remacha, Angel F.
    Puget, Guiomar
    Nomdedeu, Josep F.
    Estivill, Camino
    Pilar Sarda, M.
    Canals, Carme
    MEDICINA CLINICA, 2006, 127 (16): : 601 - 604
  • [24] Molecular mimicry in the chronic myeloproliferative disorders: Reciprocity between JAK2 V617F genotype and Mpl expression
    Moliterno, AR
    Williams, DM
    Rogers, O
    Spivak, JL
    BLOOD, 2005, 106 (11) : 983A - 983A
  • [25] Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression
    Moliterno, Alison R.
    Williams, Donna M.
    Rogers, Ophelia
    Spivak, Jerry L.
    BLOOD, 2006, 108 (12) : 3913 - 3915
  • [26] Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
    Jones, AV
    Kreil, S
    Zoi, K
    Waghorn, K
    Curtis, C
    Zhang, LY
    Score, J
    Seear, R
    Chase, AJ
    Grand, FH
    White, H
    Zoi, C
    Loukopoulos, D
    Terpos, E
    Vervessou, EC
    Schultheis, B
    Emig, M
    Ernst, T
    Lengfelder, E
    Hehlmann, R
    Hochhaus, A
    Oscier, D
    Silver, RT
    Reiter, A
    Cross, NCP
    BLOOD, 2005, 106 (06) : 2162 - 2168
  • [27] Relation between JAK2 V617F mutation and chronic myeloproliferative disorders
    Xiao, Zhjian
    Zhang, Yue
    Wang, Jianxiang
    Hao, Yushu
    BLOOD, 2007, 110 (11) : 233B - 233B
  • [28] Diagnostic assays for the JAK2 V617F mutation in chronic myeloproliferative disorders
    Greiner, TC
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 125 (05) : 651 - 653
  • [29] JAK2 and MPL gene mutations in V617F-negative myeloproliferative neoplasms
    Siemiatkowska, Anna
    Bieniaszewska, Maria
    Hellmann, Andrzej
    Limon, Janusz
    LEUKEMIA RESEARCH, 2010, 34 (03) : 387 - 389
  • [30] Budd Chiari syndrome and V617F/JAK 2 mutation linked with the myeloproliferative disorders
    Smira, Gabriela
    Gheorghe, Liana
    Lacob, Speranta
    Coriu, Dan
    Gheorghe, Cristian
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2010, 19 (01) : 108 - 109
12345